Good News for Smoking Cessation Drugs: Not as Scary as Once Thought
The Carlat Addiction Treatment Report, Volume 4, Number 5, June 2016
https://www.thecarlatreport.com/newsletter-issue/catrv4n5/
Issue Links: Learning Objectives | Editorial Information
Topics: Research Updates | Smoking Cessation Agents
Bret A. Moore, PsyD, ABPP
Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.
You can't view details of this content, please login or buy subscription here
Bret A. Moore, PsyD, ABPP
Board-Certified Clinical Psychologist, San Antonio, TX
Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.